White Paper of the GAPL 2 Project: Enhancing Sustainability in Tertiary Packaging for Pharma Air Cargo
Pharma.Aero has released the White Paper showcasing the findings of the sustainability project focusing on the tertiary packaging in the pharmaceutical air cargo. Aimed at advancing the sustainability of tertiary packaging in pharmaceutical air cargo, the project is the result of a broad global collaboration, incorporating insights from 160+ manufacturers, logistics providers, airports, and other key stakeholders across the supply chain.
Read the White Paper here
Pharma.Aero launched GAPL 2, the second phase of its Green Air Pharma Logistics initiative, to improve the sustainability of tertiary packaging used in transporting temperature-sensitive pharmaceuticals. Building on GAPL 1, which introduced the Lane Sustainability Readiness Index (LSRI), this phase focused on developing a comprehensive assessment framework through collaboration with over 160 stakeholders. The framework evaluates packaging solutions based on environmental criteria like carbon footprint, water use, reusability, and recyclability, and integrates with the LSRI to guide industry decisions. GAPL 2 emphasizes that sustainable packaging is a shared responsibility and a critical step toward reducing emissions and advancing circular, climate-conscious logistics.
Key Highlights
- Packaging Innovations & Smart Technologies
- Circular Economy Strategies
- Sustainability Criteria & Assessment Indicators
- Cross-Value Chain Collaboration
The GAPL 2 project brought together 160+ global stakeholders across the pharmaceutical logistics ecosystem to co-create practical solutions and frameworks that advance climate goals, reduce waste, and improve packaging sustainability. Pharma.Aero invites stakeholders across the industry to engage with this research and join efforts to enhance security standards.
Explore all Pharma.Aero Projects
We sincerely thank all our members and partners who generously participated in this project’s workshops, interviews and survey—your shared insights and expertise were instrumental in shaping the depth, relevance, and impact of this project.
The more detailed, in-depth Technical Report of this project is available for Pharma.Aero members only, in the Member Area of the website, here.
Not yet a member? Learn more about memberships and benefits.